Szela Mary T. - 13 Feb 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Mary Szela
Issuer symbol
TLSI
Transactions as of
13 Feb 2024
Net transactions value
$0
Form type
4
Filing time
14 Feb 2024, 18:44:45 UTC
Previous filing
15 Aug 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +84,899 +30% $0.000000 364,862 13 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +288,750 $0.000000 288,750 13 Feb 2024 Common Stock 288,750 $9.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 13, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 13, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.